In 2014, the UAB Comprehensive Cancer Center received a $2.5 million grant from the National Cancer Institute as a National Clinical Trial Network Lead Academic Participating Site.
The five-year grant, which awards $497,800 annually, allows the Cancer Center to be part of NCI’s primary infrastructure to conduct state-of-the-art cancer treatment and advanced imaging clinical trials, especially large, definitive multi-institutional trials evaluating new cancer therapies and related clinical approaches for both adult and pediatric patients.
The UAB Comprehensive Cancer Center is one of 30 cancer centers in the nation, and one of only five in the Southeast, to serve as a Lead Academic Participating Site in the NCTN.
The NCTN grant reflects the collaborative nature of the Cancer Center, involving hematology and oncology, radiation oncology, gynecologic oncology, and radiology. Principal investigator is Ronald Alvarez, M.D. (pictured at right)
Co-principal investigators include Cancer Center faculty members Jennifer De Los Santos, M.D., Warner Huh, M.D., Harry Erba, M.D., Ph.D., Desiree Morgan, M.D., Carla Falkson, M.D., and Andres Forero, M.D.
For more information about clinical trials at the UAB Comprehensive Cancer Center, call (205) 934-0309.